Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

BRAF V600E -Mutated Histiocytic Sarcoma Presenting on a Background of Clonal Cytopenia Responsive to Dabrafenib: Case Report and Review of the Literature

Alex Mitchell, Chris Bacon, Annette Nicolle, Matthew Collin

Blood (2024) 144 (Supplement 1): 6653.

https://doi.org/10.1182/blood-2024-202968

Published: 2024

Journal Articles

Dose De-Escalation of Alemtuzumab in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation: A Single Centre Retrospective Study

Maymoon Mohammed Madkhali, Alex Mitchell, Callum Wright, Kim Pearce, Sarah Pagan, Louise Duncan, Jamie Macdonald, Jason Lam, Paul Milne, Amy Publicover, Erin Hurst, Venetia Bigley, Geoff Hale, Matthew Collin

Blood (2024) 144 (Supplement 1): 7275.

https://doi.org/10.1182/blood-2024-199056

Published: 2024

Journal Articles

Efficacy and Tolerability of Trametinib in Adults with Histiocytic Neoplasms

Rodothea Amerikanou, Tahla Munir, Kristian Bowles, Christopher McNamara, Nikesh Dhiraj Chavda, Azeem Ahmed, Jagdish Adiyodi, Alasdair Coles, Philippa Kelsey, Jeffery Smith, Richard Adams, Hayder KA Hussein, Rui Zhao, Amelia Taylor, Trung Nguyen, Satyen Gohil, Matthew Collin

Blood (2024) 144 (Supplement 1): 1802.

https://doi.org/10.1182/blood-2024-204648

Published: 2024

Journal Articles

Outcome of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Wilms Tumor 1 (WT1) Mutation: A Study from the ALWP/EBMT

Blood (2024) 144 (Supplement 1): 2188.

https://doi.org/10.1182/blood-2024-200501

Published: 2024

Journal Articles

Impact of Fludarabine Dosage on Outcomes in Large B-Cell Lymphoma Patients Treated with CAR T-Cell Therapy: A Retrospective Study on Behalf of the Ctiwp of the EBMT

Blood (2024) 144 (Supplement 1): 3456.

https://doi.org/10.1182/blood-2024-211010

Published: 2024

Journal Articles

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

Blood (2024) 144 (Supplement 1): 4315.

https://doi.org/10.1182/blood-2024-202764

Published: 2024

Journal Articles

Prognostic Value of BRAFV600E in Peripheral Blood of Children with Langerhans Cell Histiocytosis: A Multicenter Project of the European Consortium for Histiocytosis

Linda Beneforti, Paul Milne, Aurora Chinnici, Maria Luisa Coniglio, Sébastien Héritier, Astrid Van Halteren, Caroline Hutter, Irene Trambusti, Francesco Pegoraro, Zofia Hélias-Rodzewicz, Raphaela Schwentner, Natasja Roozeboom, Michele Tanturli, Jean-Francois Emile, Cor Van Den Bos, Milen Minkov, Jean Donadieu, Matthew Collin, Elena Sieni

Blood (2024) 144 (Supplement 1): 3908.

https://doi.org/10.1182/blood-2024-206118

Published: 2024

Journal Articles

Frequency and Impact of Somatic Mutations Alone or in Combination on Post-Transplant Outcomes in Acute Myeloid Leukemia: A Large Study on Behalf of the EBMT Acute Leukemia Working Party

Blood (2024) 144 (Supplement 1): 4942.

https://doi.org/10.1182/blood-2024-204672

Published: 2024

Journal Articles

Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT

Blood (2024) 144 (3): 323–333.

https://doi.org/10.1182/blood.2024024173

Published: 2024

Journal Articles

Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma

Benjamin J. Stewart, Martin Fergie, Matthew D. Young, Claire Jones, Ashwin Sachdeva, Alex Blain, Chris M. Bacon, Vikki Rand, John R. Ferdinand, Kylie R. James, Krishnaa T. Mahbubani, Liz Hook, Nicolaas Jonas, Nicholas Coleman, Kourosh Saeb-Parsy, Matthew Collin, Menna R. Clatworthy, Sam Behjati, Christopher D. Carey

Blood (2023) 141 (19): 2343–2358.

https://doi.org/10.1182/blood.2022015575

Published: 2023

Includes: Supplemental data

Journal Articles

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

Ricky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, Vasily V. Grinev, Anetta Ptasinska, Paulynn S. Chin, Claus Meyer, Sirintra Nakjang, Jayne Y. Hehir-Kwa, Daniel Williamson, Pierre Cauchy, Peter Keane, Salam A. Assi, Minoo Ashtiani, Sophie G. Kellaway, Maria R. Imperato, Fotini Vogiatzi, Elizabeth K. Schweighart, Shan Lin, Mark Wunderlich, Janine Stutterheim, Alexander Komkov, Elena Zerkalenkova, Paul Evans, Hesta McNeill, Alex Elder, Natalia Martinez-Soria, Sarah E. Fordham, Yuzhe Shi, Lisa J. Russell, Deepali Pal, Alex Smith, Zoya Kingsbury, Jennifer Becq, Cornelia Eckert, Oskar A. Haas, Peter Carey, Simon Bailey, Roderick Skinner, Natalia Miakova, Matthew Collin, Venetia Bigley, Muzlifah Haniffa, Rolf Marschalek, Christine J. Harrison, Catherine A. Cargo, Denis Schewe, Yulia Olshanskaya, Michael J. Thirman, Peter N. Cockerill, James C. Mulloy, Helen J. Blair, Josef Vormoor, James M. Allan, Constanze Bonifer, Olaf Heidenreich, Simon Bomken

Blood (2022) 140 (17): 1875–1890.

https://doi.org/10.1182/blood.2021015036

Published: 2022

Includes: Supplemental data

Journal Articles

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

Gaurav Goyal, Abdellatif Tazi, Ronald S. Go, Karen L. Rech, Jennifer L. Picarsic, Robert Vassallo, Jason R. Young, Christian W. Cox, Jan Van Laar, Michelle L. Hermiston, Xin-Xin Cao, Polyzois Makras, Gregory Kaltsas, Julien Haroche, Matthew Collin, Kenneth L. McClain, Eli L. Diamond, Michael Girschikofsky

Blood (2022) 139 (17): 2601–2621.

https://doi.org/10.1182/blood.2021014343

Published: 2022

Includes: Supplemental data

Journal Articles

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Möhle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Méry, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Muñoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-François Emile

Blood (2022) 139 (2): 256–280.

https://doi.org/10.1182/blood.2021013338

Published: 2022

Includes: Supplemental data

Journal Articles

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

Blood (2020) 135 (22): 1929–1945.

https://doi.org/10.1182/blood.2019003507

Published: 2020

Journal Articles

In vivo T-depleted reduced-intensity transplantation for GATA2 -related immune dysfunction

Eleni Tholouli, Katherine Sturgess, Rachel E. Dickinson, Andrew Gennery, Andrew J. Cant, Graham Jackson, Jim Lordan, Sophie Hambleton, Mary A. Slatter, Venetia Bigley, Matthew Collin

Blood (2018) 131 (12): 1383–1387.

https://doi.org/10.1182/blood-2017-10-811489

Published: 2018

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Blood (2017) 130 (Supplement 1): 3273.

https://doi.org/10.1182/blood.V130.Suppl_1.3273.3273

Published: 2017

Journal Articles

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

Paul Milne, Venetia Bigley, Chris M. Bacon, Antoine Néel, Naomi McGovern, Simon Bomken, Muzlifah Haniffa, Eli L. Diamond, Benjamin H. Durham, Johannes Visser, David Hunt, Harsha Gunawardena, Mac Macheta, Kenneth L. McClain, Carl Allen, Omar Abdel-Wahab, Matthew Collin

Blood (2017) 130 (2): 167–175.

https://doi.org/10.1182/blood-2016-12-757823

Published: 2017

Includes: Supplemental data

Journal Articles

I am SAMD9L : 7q regulator I am

Matthew Collin

Blood (2017) 129 (16): 2210–2212.

https://doi.org/10.1182/blood-2017-03-770198

Published: 2017

Journal Articles

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells

Blood (2017) 129 (14): 1927–1939.

https://doi.org/10.1182/blood-2016-08-734236

Published: 2017

Includes: Supplemental data

Journal Articles

Inhibition of ATR in Combination with Nucleoside Analogues Eradicates Acute Myeloid Leukaemia in an Orthotopic Murine Xenograft Model

Sarah E Fordham, PhD, Helen J Blair, PhD, Claire J Elstob, PhD, Deepali Pal, PhD, Nicola Curtin, PhD, Paul Milne, PhD, Matthew Collin, MD PhD, Graham H Jackson, MD MBBS, Helen J Marr, MD PhD, Olaf Heidenreich, PhD, Ruth Plummer, John Pollard, PhD, Tobias F. Menne, MD PhD FRCPath, Gail L Jones, MD BMBS, James M Allan, DPhil

Blood (2016) 128 (22): 4031.

https://doi.org/10.1182/blood.V128.22.4031.4031

Published: 2016

NARROW

BRAF V600E -Mutated Histiocytic Sarcoma Presenting on a Background of Clonal Cytopenia Responsive to Dabrafenib: Case Report and Review of the Literature

Dose De-Escalation of Alemtuzumab in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation: A Single Centre Retrospective Study

Efficacy and Tolerability of Trametinib in Adults with Histiocytic Neoplasms

Outcome of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia with Wilms Tumor 1 (WT1) Mutation: A Study from the ALWP/EBMT

Impact of Fludarabine Dosage on Outcomes in Large B-Cell Lymphoma Patients Treated with CAR T-Cell Therapy: A Retrospective Study on Behalf of the Ctiwp of the EBMT

In AML Patients Allografted in First Remission, DNMT3A Mutations Differentially Affect Post-Transplant Outcomes According to Karyotype, NPM1 and FLT3-ITD Mutation Status - from the EBMT-ALWP

Prognostic Value of BRAFV600E in Peripheral Blood of Children with Langerhans Cell Histiocytosis: A Multicenter Project of the European Consortium for Histiocytosis

Frequency and Impact of Somatic Mutations Alone or in Combination on Post-Transplant Outcomes in Acute Myeloid Leukemia: A Large Study on Behalf of the EBMT Acute Leukemia Working Party

Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT

Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

In vivo T-depleted reduced-intensity transplantation for GATA2 -related immune dysfunction

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

I am SAMD9L : 7q regulator I am

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells

Inhibition of ATR in Combination with Nucleoside Analogues Eradicates Acute Myeloid Leukaemia in an Orthotopic Murine Xenograft Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only